Trading Tips Blog

Cynthia Flanders, a director at
Argan (AGX), recently bought 8,500 shares. The buy increased her position by 106 percent, and came to a total cost just under $258,000. This follows up on two buys from another director in April and May, for 2,000 shares. Those mark the only insider moves since late 2021, when the company chairman sold off 10,000 shares at far higher prices than where the stock trades today. Overall, company insiders own 5.8 percent of shares. The engineering and construction ...
Read More About This

Retailer
Abercrombie & Fitch (ANF) is having a banner year, with a 276 percent rally in shares. One trader sees that rally continuing in the weeks ahead. That’s based on the December 15 $80 calls. With 59 days until expiration, 2,309 contracts traded compared to a prior open interest of 112, for a 21-fold rise in volume on the trade. The buyer of the calls paid $1.05 to make the bullish bet. Shares recently traded for just over $60, so they would ...
Read More About This

The stock market usually moves higher due to just a handful of companies. Today, that’s centered around big-cap tech stocks working on artificial intelligence (AI) programs. In time, that may change. But while big names get the attention, companies that provide key services and supplies can also be big winners. That’s especially true after the big names have gotten the market’s attention and have run higher. Investing in suppliers can also provide useful signals as to the health of the economy. For ...
Read More About This

Randall Weisenburger, a director at
Carnival Corp (CCL), recently bought 350,000 shares. The buy increased his stake by 39 percent, and came to a total cost of $4.54 million. The director was the last buyer of shares in May 2022, with a 100,000 share buy, coming to a total cost of just under $1.2 million. The company CFO sold about one-quarter of his position back in February, marking the only insider sale in the past year. Overall, company insiders own 8 percent ...
Read More About This

Financial services leader
Morgan Stanley (MS) is trading flat over the past year, as the banking sector has been under pressure from higher interest rates and slow stock trading. One trader is betting shares will take a hit in the coming months. That’s based on the December 15 $60 puts. With 58 days until expiration, 9,965 contracts traded compared to a prior open interest of 162, for a 62-fold rise in volume on the trade. The buyer of the puts paid $0.27. Morgan ...
Read More About This

The past few weeks have seen several snack food companies take a big hit. Part of the move may have been from rising bond yields, which compete with dividend yields. Another factor is the use of Ozempic, a weight loss drug. Either way, shares of these companies have dropped off considerably in recent weeks, and now look like long-term buys. Weight loss drugs are nothing new, and many will still want to enjoy snacks or satisfy their sweet tooth. While headlines have ...
Read More About This

Isabelle Parize, a director at
Coty (COTY), recently bought 4,775 shares. The buy increased her stake by 8 percent, and came to a total cost of just over $50,100. The buy was a follow-up from a buy the prior week for 20,500 shares, which increased her sake by 57 percent and came to nearly $211,000. A major holder also bought 3 million shares earlier in the month, paying $32.4 million. All told, company insiders own 60.1 percent of the cosmetics company, and ...
Read More About This

Dialysis machine manufacturer
Baxter International (BAX) is down nearly a third over the past year. Part of the recent selloff comes as new weight loss drugs have come onto the market. One trader is betting that shares have overreacted. That’s based on the January 2024 $35 calls. With 98 days until expiration, 6,917 contracts traded compared to a prior open interest of 205, for a 34-fold rise in volume. The buyer of the calls paid $1.50 to make the bullish bet. Shares Read More About This